Apogee Therapeutics, Inc. (APGE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Apogee Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -17.91x | -13.73x | -16.85x | -27.04x |
| P/B Ratio | 5.07x | 3.49x | 3.73x | 7.57x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 26.57x | 18.55x | 19.38x | 15.24x |
| Quick Ratio | 26.57x | 18.55x | 19.38x | 15.24x |
| Leverage | ||||
| Debt/Equity | 0.01x | 0.02x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..